Insider · CIK 0001880094
Carter Xavier
Files at TCRG (Cannaisseur Group Inc.). First filing -, latest -.
In brief
Carter Xavier files SEC Form 4 as CFO and director at TCRG (Cannaisseur Group Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carter Xavier has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | TCRG Cannaisseur Group Inc. | AGrant or award COMMON | -1,000,000 | $0.27 | $272k | 11,100,000 | Aug 15, 2025 |
| Feb 4, 2025 | TCRG Cannaisseur Group Inc. | AGrant or award Common Stock - Par Value 0.0001 | +2,000,000 | $0.00 | $0 | 10,100,000 | Feb 6, 2025 |
| Jun 4, 2024 | TCRG Cannaisseur Group Inc. | AGrant or award Common Stock - Par Value 0.0001 | +1,300,000 | $0.00 | $0 | 8,100,000 | Jul 16, 2024 |
| Mar 20, 2024 | TCRG Cannaisseur Group Inc. | GGift Common Stock - Par Value 0.0001 | -700,000 | $0.00 | $0 | 6,100,000 | Mar 22, 2024 |
Questions about Carter Xavier
Answered from the filings on this page, as of the latest one.
Is Carter Xavier buying or selling?
Carter Xavier has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carter Xavier's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carter Xavier has 0.
Where does Carter Xavier file Form 4?
Carter Xavier has filed Form 4 at TCRG (Cannaisseur Group Inc.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.